- Report
- April 2023
- 68 Pages
Canada
From €4201EUR$4,750USD£3,627GBP
- Report
- April 2023
- 85 Pages
Argentina
From €4201EUR$4,750USD£3,627GBP
- Report
- April 2023
- 68 Pages
Japan
From €4201EUR$4,750USD£3,627GBP
- Report
- August 2022
- 75 Pages
United States
From €4201EUR$4,750USD£3,627GBP
- Report
- August 2022
- 76 Pages
India
From €4201EUR$4,750USD£3,627GBP
- Report
- January 2024
- 200 Pages
Global
From €3670EUR$4,150USD£3,169GBP
- Report
- January 2024
- 200 Pages
Global
From €3670EUR$4,150USD£3,169GBP
- Report
- January 2024
- 200 Pages
Global
From €3670EUR$4,150USD£3,169GBP
- Report
- October 2023
- 145 Pages
Global
From €2786EUR$3,150USD£2,405GBP
- Report
- October 2023
- 145 Pages
Global
From €2786EUR$3,150USD£2,405GBP
- Report
- August 2023
- 145 Pages
Global
From €2786EUR$3,150USD£2,405GBP
- Report
- January 2024
- 86 Pages
North America
From €3051EUR$3,450USD£2,634GBP
- Report
- January 2024
- 87 Pages
Asia Pacific
From €3051EUR$3,450USD£2,634GBP
- Report
- January 2024
- 147 Pages
Global
From €3007EUR$3,400USD£2,596GBP
€3759EUR$4,250USD£3,245GBP
- Report
- October 2023
- 133 Pages
North America
From €3051EUR$3,450USD£2,634GBP
- Report
- October 2023
- 125 Pages
Middle East, Africa
From €3051EUR$3,450USD£2,634GBP
- Report
- October 2023
- 123 Pages
From €3051EUR$3,450USD£2,634GBP
- Report
- October 2023
- 146 Pages
Europe
From €3051EUR$3,450USD£2,634GBP
- Report
- October 2023
- 142 Pages
Asia Pacific
From €3051EUR$3,450USD£2,634GBP
- Report
- March 2022
- 390 Pages
Global
From €3935EUR$4,450USD£3,398GBP

The Cardiac Valve market is a segment of the Cardiovascular Devices industry, which includes a range of products used to diagnose and treat heart conditions. Cardiac valves are used to regulate the flow of blood through the heart, and can be either mechanical or biological. Mechanical valves are typically made of metal and are designed to last for many years, while biological valves are made of animal tissue and are designed to be replaced over time. Both types of valves are used to treat a variety of heart conditions, including aortic stenosis, mitral regurgitation, and tricuspid regurgitation.
The Cardiac Valve market is highly competitive, with a number of companies offering a range of products. Major players in the market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and LivaNova. Other companies in the market include CryoLife, Symetis, and Neovasc. Show Less Read more